Pineapples and green tea: FDA turns to public for new approaches to botanical drugs - Pharmaceutical Technology

The FDA is looking to modernise its regulatory framework for drugs derived from plants, algae, and fungi. The FDA is looking to modernise its regulatory framework for drugs derived from plants, algae, and fungi. The FDA has so far approved four botanical products, with a view to greenlight more. Credit: Svetliy/Shutterstock.com. The US Food and Drug Administration (FDA) is requesting public input on both the opportunities and challenges regarding drugs derived from botanical sources. Botanical drug products are those developed from one or a combination of plants, algae, or macroscopic fungi. While there are approved drugs in this class, their…

Source: Pharmaceutical Technology